Northeast Pharmaceutical Group Co Ltd (000597) — Cash Flow Reinvestment Rate
Northeast Pharmaceutical Group Co Ltd (000597) has a Cash Flow Reinvestment Rate of 0.04x as of September 2025, reinvesting CN¥11.48 Million (capex CN¥11.48 Million ) from operating cash flow of CN¥274.09 Million. See Northeast Pharmaceutical Group Co Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Northeast Pharmaceutical Group Co Ltd Cash Flow Reinvestment Rate (1999–2025)
Historical reinvestment intensity for Northeast Pharmaceutical Group Co Ltd across 23 annual periods. For the full cash flow conversion analysis, see 000597 cash generation efficiency.
Annual Cash Flow Reinvestment Rate for Northeast Pharmaceutical Group Co Ltd (1999–2025)
Year-by-year capital reinvestment analysis for Northeast Pharmaceutical Group Co Ltd. See Northeast Pharmaceutical Group Co Ltd (000597) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.09x | CN¥100.65 Million | CN¥1.11 Billion | CN¥97.78 Million | ▼ -84.4% |
| 2024 | 0.58x | CN¥443.39 Million | CN¥758.76 Million | CN¥159.43 Million | ▼ -26.0% |
| 2023 | 0.79x | CN¥463.40 Million | CN¥586.75 Million | CN¥235.43 Million | ▲ +74.9% |
| 2022 | 0.45x | CN¥500.47 Million | CN¥1.11 Billion | CN¥244.13 Million | ▲ +148.3% |
| 2021 | 0.18x | CN¥135.71 Million | CN¥746.51 Million | CN¥119.81 Million | ▼ -75.1% |
| 2020 | 0.73x | CN¥416.28 Million | CN¥570.92 Million | CN¥400.38 Million | ▲ +4.9% |
| 2019 | 0.70x | CN¥245.06 Million | CN¥352.60 Million | CN¥229.17 Million | ▼ -65.9% |
| 2018 | 2.04x | CN¥581.64 Million | CN¥285.09 Million | CN¥565.74 Million | ▲ +10.2% |
| 2016 | 1.85x | CN¥712.04 Million | CN¥384.51 Million | CN¥177.01 Million | ▼ -74.2% |
| 2015 | 7.18x | CN¥716.04 Million | CN¥99.70 Million | CN¥346.04 Million | ▼ -36.6% |
| 2014 | 11.33x | CN¥532.27 Million | CN¥46.99 Million | CN¥532.27 Million | ▲ +445.1% |
| 2012 | 2.08x | CN¥178.90 Million | CN¥86.09 Million | CN¥178.90 Million | ▲ +12.2% |
| 2010 | 1.85x | CN¥473.93 Million | CN¥255.96 Million | CN¥473.93 Million | ▲ +32.2% |
| 2009 | 1.40x | CN¥862.78 Million | CN¥615.91 Million | CN¥862.78 Million | ▲ +176.5% |
| 2008 | 0.51x | CN¥359.27 Million | CN¥709.03 Million | CN¥359.27 Million | ▲ +14.6% |
| 2007 | 0.44x | CN¥87.78 Million | CN¥198.56 Million | CN¥87.78 Million | ▼ -52.5% |
| 2005 | 0.93x | CN¥103.66 Million | CN¥111.40 Million | CN¥103.66 Million | ▲ +221.2% |
| 2004 | 0.29x | CN¥61.14 Million | CN¥211.06 Million | CN¥61.14 Million | ▼ -23.8% |
| 2003 | 0.38x | CN¥87.46 Million | CN¥230.08 Million | CN¥87.46 Million | ▲ +57.1% |
| 2002 | 0.24x | CN¥38.07 Million | CN¥157.41 Million | CN¥38.07 Million | ▼ -59.1% |
| 2001 | 0.59x | CN¥46.57 Million | CN¥78.84 Million | CN¥46.57 Million | ▲ +75.2% |
| 2000 | 0.34x | CN¥12.18 Million | CN¥36.13 Million | CN¥12.18 Million | ▲ +95.9% |
| 1999 | 0.17x | CN¥9.41 Million | CN¥54.62 Million | CN¥9.41 Million | — |